Form 4 for CRTO Criteo S.A.
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-14 · accession 0001576427-22-000130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-15 | 2022-12-14 | CRTO | WARNER JAMES | Dir | M - OptEx | $10.29 | +30.6K | 37.8K | +428% | +$314.9K |
| DM | 2022-12-15 | 2022-12-14 | CRTO | WARNER JAMES | Dir | S - Sale+OE | $25.90 | -30.6K | 27.6K | -53% | -$792.5K |
| DM | 2022-12-15 | 2022-12-14 | CRTO | WARNER JAMES | Dir | M - OptEx | $0.00 | -30.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-12-14 | M | A | 20,400 | $10.29 | 47,953 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
| 2 | Common | Ordinary Shares | 2022-12-14 | S | D | 20,400 | $25.90 | 27,553 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
| 3 | Common | Ordinary Shares | 2022-12-14 | M | A | 10,200 | $10.29 | 37,753 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
| 4 | Common | Ordinary Shares | 2022-12-14 | S | D | 10,200 | $25.90 | 27,553 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
| 5 | Derivative | Non-employee Warrant (right to buy) | 2022-12-14 | M | D | 20,400 | $0.00 | 0 | D | $10.29 · — to 2023-02-07 | 20,400 Ordinary Shares | (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. (F2) The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). (F5) Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023. |
| 6 | Derivative | Non-employee Warrant (right to buy) | 2022-12-14 | M | D | 10,200 | $0.00 | 0 | D | $10.29 · — to 2023-03-06 | 10,200 Ordinary Shares | (F3) For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. (F2) The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). (F6) Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023. |